Benjamin Ambrosy

2PUBLICATIONS
9CO-AUTHORS
Animal protection (incl. pests and pathogens)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 20, 2025
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib.

André Schreiber, Nicole Oberberg, Benjamin Ambrosy

|Sep 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs.

André Schreiber, Benjamin Ambrosy, Oliver Planz

Pageof 1

Frequent Collaborators

2 joint publications

André Schreiber

2 joint publications

Stephan Ludwig

1 joint publications

Oliver Planz

1 joint publications

Ursula Rescher